Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice Journal title: Нирки Authors: Ron T. Gansevoort, Mustafa Arici, Thomas Benzing Subject(s):
Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases Journal title: Journal of Clinical Research in Pediatric Endocrinology Authors: Gerdi Tuli, Daniele Tessaris, Silvia Einaudi, Luisa De Sanctis, Patrizia Matarazzo Subject(s): Medicine, Internal Medicine, Pediatrics
Tolvaptan in Heart Failure: A Review Journal title: International Journal of Innovative Research in Medical Science Authors: Dr. Mayuresh Kiran, Ms. Priyanka Shah Subject(s):
Comparison of Diuretic Effects between Empagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor With Osmotic Diuresis, and Tolvaptan, a Water Diuretic, in Two Type 2 Diabetic Patients Taking Sodium Diuretics Journal title: Diabetes Research – Open Journal Authors: Yuji Aoki Subject(s):
Review of the REPRISE Trial: Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease Journal title: Nephrology – Open Journal Authors: Soroush Nomigolzar, Himax Patel Subject(s):
Efficiency of Single Dose of Tolvaptan Treatment During the Triphasic Episode After Surgery for Craniopharyngioma Journal title: Journal of Clinical Research in Pediatric Endocrinology Authors: Fatih Gürbüz, Mehmet Taştan, İhsan Turan, Bilgin Yüksel Subject(s): Medicine, Internal Medicine, Pediatrics
